Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel Isatin-Thiazole Derivatives as α-Glucosidase Inhibitors. 2017

Zhenzhen Xie, and Guangcheng Wang, and Jing Wang, and Ming Chen, and Yaping Peng, and Luyao Li, and Bing Deng, and Shan Chen, and Wenbiao Li
College of Chemistry and Chemical Engineering, Hunan Engineering Laboratory for Analyse and Drugs Development of Ethnomedicine in Wuling Mountains, Jishou University, Jishou 416000, China. xiezz1993@126.com.

A series of novel isatin-thiazole derivatives were synthesized and screened for their in vitro α-glucosidase inhibitory activity. These compounds displayed a varying degree of α-glucosidase inhibitory activity with IC50 ranging from 5.36 ± 0.13 to 35.76 ± 0.31 μm as compared to the standard drug acarbose (IC50 = 817.38 ± 6.27 μm). Among the series, compound 6p bearing a hydroxyl group at the 4-position of the right phenyl and 2-fluorobenzyl substituent at the N1-positions of the 5-methylisatin displayed the highest inhibitory activity with an IC50 value of 5.36 ± 0.13 μm. Molecular docking studies revealed the existence of hydrophobic interaction, CH-π interaction, arene-anion interaction, arene-cation interaction, and hydrogen bond between these compounds and α-glucosidase enzyme.

UI MeSH Term Description Entries
D007510 Isatin An indole-dione that is obtained by oxidation of indigo blue. It is a MONOAMINE OXIDASE INHIBITOR and high levels have been found in urine of PARKINSONISM patients. 2,3-Dioxoindoline,2,3 Dioxoindoline
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D000520 alpha-Glucosidases Enzymes that catalyze the exohydrolysis of 1,4-alpha-glucosidic linkages with release of alpha-glucose. Deficiency of alpha-1,4-glucosidase may cause GLYCOGEN STORAGE DISEASE TYPE II. Acid Maltase,Lysosomal alpha-Glucosidase,Maltase,Maltases,Maltase-Glucoamylase,Neutral Maltase,Neutral alpha-Glucosidase,alpha-Glucosidase,Lysosomal alpha Glucosidase,Maltase Glucoamylase,Neutral alpha Glucosidase,alpha Glucosidase,alpha Glucosidases,alpha-Glucosidase, Lysosomal,alpha-Glucosidase, Neutral
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013844 Thiazoles Heterocyclic compounds where the ring system is composed of three CARBON atoms, a SULFUR and NITROGEN atoms. Thiazole
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D056004 Molecular Dynamics Simulation A computer simulation developed to study the motion of molecules over a period of time. Molecular Dynamics Simulations,Molecular Dynamics,Dynamic, Molecular,Dynamics Simulation, Molecular,Dynamics Simulations, Molecular,Dynamics, Molecular,Molecular Dynamic,Simulation, Molecular Dynamics,Simulations, Molecular Dynamics
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking
D065089 Glycoside Hydrolase Inhibitors Compounds that inhibit or block the activity of GLYCOSIDE HYDROLASES such as ALPHA-AMYLASES and ALPHA-GLUCOSIDASES. alpha-Glucosidase Inhibitor,alpha-Glucosidase Inhibitors,Intestinal alpha-Amylase Inhibitors,Pancreatic alpha-Amylase Inhibitors,alpha-Amylase Inhibitors, Pancreatic,Hydrolase Inhibitors, Glycoside,Inhibitor, alpha-Glucosidase,Inhibitors, Glycoside Hydrolase,Inhibitors, Intestinal alpha-Amylase,Inhibitors, Pancreatic alpha-Amylase,Inhibitors, alpha-Glucosidase,Intestinal alpha Amylase Inhibitors,Pancreatic alpha Amylase Inhibitors,alpha Amylase Inhibitors, Pancreatic,alpha Glucosidase Inhibitor,alpha Glucosidase Inhibitors,alpha-Amylase Inhibitors, Intestinal

Related Publications

Zhenzhen Xie, and Guangcheng Wang, and Jing Wang, and Ming Chen, and Yaping Peng, and Luyao Li, and Bing Deng, and Shan Chen, and Wenbiao Li
March 2017, Chemical biology & drug design,
Zhenzhen Xie, and Guangcheng Wang, and Jing Wang, and Ming Chen, and Yaping Peng, and Luyao Li, and Bing Deng, and Shan Chen, and Wenbiao Li
October 2015, Bioorganic chemistry,
Zhenzhen Xie, and Guangcheng Wang, and Jing Wang, and Ming Chen, and Yaping Peng, and Luyao Li, and Bing Deng, and Shan Chen, and Wenbiao Li
April 2016, Bioorganic chemistry,
Zhenzhen Xie, and Guangcheng Wang, and Jing Wang, and Ming Chen, and Yaping Peng, and Luyao Li, and Bing Deng, and Shan Chen, and Wenbiao Li
August 2018, Bioorganic chemistry,
Zhenzhen Xie, and Guangcheng Wang, and Jing Wang, and Ming Chen, and Yaping Peng, and Luyao Li, and Bing Deng, and Shan Chen, and Wenbiao Li
November 2016, Bioorganic & medicinal chemistry,
Zhenzhen Xie, and Guangcheng Wang, and Jing Wang, and Ming Chen, and Yaping Peng, and Luyao Li, and Bing Deng, and Shan Chen, and Wenbiao Li
March 2023, BMC chemistry,
Zhenzhen Xie, and Guangcheng Wang, and Jing Wang, and Ming Chen, and Yaping Peng, and Luyao Li, and Bing Deng, and Shan Chen, and Wenbiao Li
June 2015, Bioorganic chemistry,
Zhenzhen Xie, and Guangcheng Wang, and Jing Wang, and Ming Chen, and Yaping Peng, and Luyao Li, and Bing Deng, and Shan Chen, and Wenbiao Li
February 2015, Bioorganic chemistry,
Zhenzhen Xie, and Guangcheng Wang, and Jing Wang, and Ming Chen, and Yaping Peng, and Luyao Li, and Bing Deng, and Shan Chen, and Wenbiao Li
January 2017, European journal of medicinal chemistry,
Zhenzhen Xie, and Guangcheng Wang, and Jing Wang, and Ming Chen, and Yaping Peng, and Luyao Li, and Bing Deng, and Shan Chen, and Wenbiao Li
September 2022, Molecules (Basel, Switzerland),
Copied contents to your clipboard!